Equity Overview
Price & Market Data
Price: $0.576
Daily Change: -$0.324 / 56.27%
Range: $0.50 - $0.879
Market Cap: $8,589,353
Volume: 3,207,733
Performance Metrics
1 Week: -69.42%
1 Month: -72.26%
3 Months: -76.71%
6 Months: -83.11%
1 Year: -86.03%
YTD: -67.85%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.